Oncology Business Management | Specialty

Immunotherapy, Personalized Medicine to Highlight Winter Hematology Meeting

February 20th 2015

Oncologists, hematologists, and other experts on hematologic malignancies will convene for the 19th Annual International Congress on Hematologic Malignancies, from February 20-21 in Miami, Florida, to provide insight into recent developments in the treatment of the diseases.

Cobimetinib Receives Priority Review for Advanced Melanoma

February 19th 2015

The FDA has granted a priority review to the MEK inhibitor cobimetinib for use in combination with the BRAF inhibitor vemurafenib (Zelboraf) to treat patients with BRAF V600–positive advanced melanoma.

FDA Approves Frontline Revlimid for Multiple Myeloma

February 18th 2015

The FDA has approved lenalidomide (Revlimid) plus dexamethasone in newly diagnosed patients with multiple myeloma based on findings from the phase III FIRST trial.

Tulane Cancer Center and Its World-Class Teams Join Onclive in Strategic Alliance Partnership Program

February 17th 2015

OncLive and Tulane Cancer Center at the Tulane University School of Medicine have joined forces to promote awareness of new developments in cancer care through OncLive's Strategic Alliance Partnership program, OncLive announced today.

COA Says New Care Model Doesn't Go Far Enough

February 13th 2015

The COA has weighed in on a new system of higher value performance for oncologists, saying it is a step in the right direction but needs to be supported by broader reforms.

Radium-223 for Treatment of Prostate Cancer

February 13th 2015

Antiandrogen Resistance With AR-V7 in CRPC

February 13th 2015

Enzalutamide Offers Second Option in Pre-Chemo CRPC

February 13th 2015

Pre-Chemotherapy Abiraterone Acetate in CRPC

February 13th 2015

Integrating CHAARTED Findings Into Prostate Cancer Care

February 13th 2015

CHAARTED Trial Changes Practice in Prostate Cancer

February 13th 2015

ADT in Prostate Cancer: Agonists Versus Antagonists

February 13th 2015

Integrating Molecular Testing Into Urology Practices

February 13th 2015

Biomarkers for Aiding Risk Stratification and Treatment Decisions

February 13th 2015

Follow-up Biomarker Testing in Prostate Cancer

February 13th 2015

Strategies for Using Biomarkers in Prostate Cancer

February 13th 2015

Rutgers Cancer Institute of New Jersey Joins OncLive Strategic Alliance Partnership Program

February 10th 2015

OncLive today welcomes Rutgers Cancer Institute of New Jersey as a partner in promoting awareness of the most recent advances in cancer care through OncLive's Strategic Alliance Partnership program

Cancer Vaccine Field Remains Lively Despite Setbacks: 10+ Agents in Advanced Testing

February 10th 2015

The only therapeutic cancer vaccine ever to win approval from the FDA has repeatedly missed sales projections, plunging the company that developed it into bankruptcy proceedings.

ABIM Rolls Back MOC Changes

February 9th 2015

The American Board of Internal Medicine (ABIM) is making substantial changes to its Maintenance of Certification Program (MOC) for internists and subspecialists.

Latest News & Insight: February 5, 2015

February 6th 2015